| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 3.44e-05 | 10 | 18 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.66e-04 | 27 | 18 | 2 | GO:0004683 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 4.49e-04 | 35 | 18 | 2 | GO:0051019 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.75e-03 | 599 | 18 | 4 | GO:0050839 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 2.10e-03 | 76 | 18 | 2 | GO:0098631 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 5.40e-06 | 40 | 18 | 3 | GO:0048679 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 8.83e-06 | 47 | 18 | 3 | GO:0070570 | |
| GeneOntologyBiologicalProcess | positive regulation of aspartic-type peptidase activity | 1.51e-05 | 7 | 18 | 2 | GO:1905247 | |
| GeneOntologyBiologicalProcess | regulation of aspartic-type peptidase activity | 2.58e-05 | 9 | 18 | 2 | GO:1905245 | |
| GeneOntologyBiologicalProcess | axon regeneration | 2.82e-05 | 69 | 18 | 3 | GO:0031103 | |
| GeneOntologyBiologicalProcess | macropinocytosis | 3.94e-05 | 11 | 18 | 2 | GO:0044351 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 4.56e-05 | 81 | 18 | 3 | GO:0031102 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 6.46e-05 | 91 | 18 | 3 | GO:0060998 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | 6.46e-05 | 519 | 18 | 5 | GO:0045088 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 7.22e-05 | 1316 | 18 | 7 | GO:0032101 | |
| GeneOntologyBiologicalProcess | negative regulation of axon regeneration | 9.71e-05 | 17 | 18 | 2 | GO:0048681 | |
| GeneOntologyBiologicalProcess | response to axon injury | 9.89e-05 | 105 | 18 | 3 | GO:0048678 | |
| GeneOntologyBiologicalProcess | regulation of defense response | 1.48e-04 | 1006 | 18 | 6 | GO:0031347 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection regeneration | 1.64e-04 | 22 | 18 | 2 | GO:0070571 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | 1.77e-04 | 643 | 18 | 5 | GO:0002831 | |
| GeneOntologyBiologicalProcess | retina layer formation | 2.13e-04 | 25 | 18 | 2 | GO:0010842 | |
| GeneOntologyBiologicalProcess | pinocytosis | 2.13e-04 | 25 | 18 | 2 | GO:0006907 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 2.16e-04 | 1077 | 18 | 6 | GO:0098609 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 2.24e-04 | 1085 | 18 | 6 | GO:0050776 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 2.37e-04 | 141 | 18 | 3 | GO:0060996 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.38e-04 | 685 | 18 | 5 | GO:0050808 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 2.63e-04 | 373 | 18 | 4 | GO:0006402 | |
| GeneOntologyBiologicalProcess | astrocyte activation | 2.88e-04 | 29 | 18 | 2 | GO:0048143 | |
| GeneOntologyBiologicalProcess | male meiosis I | 3.29e-04 | 31 | 18 | 2 | GO:0007141 | |
| GeneOntologyBiologicalProcess | positive regulation of response to external stimulus | 3.36e-04 | 738 | 18 | 5 | GO:0032103 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 4.60e-04 | 432 | 18 | 4 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 5.06e-04 | 443 | 18 | 4 | GO:1903311 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | 5.41e-04 | 451 | 18 | 4 | GO:0002833 | |
| GeneOntologyBiologicalProcess | neuron projection development | 5.60e-04 | 1285 | 18 | 6 | GO:0031175 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | 5.62e-04 | 1286 | 18 | 6 | GO:0140546 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 6.02e-04 | 464 | 18 | 4 | GO:0141188 | |
| GeneOntologyBiologicalProcess | astrocyte development | 7.60e-04 | 47 | 18 | 2 | GO:0014002 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 7.69e-04 | 211 | 18 | 3 | GO:0060041 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 8.34e-04 | 217 | 18 | 3 | GO:1903034 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 8.52e-04 | 509 | 18 | 4 | GO:0032102 | |
| GeneOntologyBiologicalProcess | defense response to other organism | 9.06e-04 | 1407 | 18 | 6 | GO:0098542 | |
| GeneOntologyBiologicalProcess | neuron development | 1.11e-03 | 1463 | 18 | 6 | GO:0048666 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.19e-03 | 974 | 18 | 5 | GO:0034330 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 1.19e-03 | 1483 | 18 | 6 | GO:0048646 | |
| GeneOntologyBiologicalProcess | microglial cell activation | 1.19e-03 | 59 | 18 | 2 | GO:0001774 | |
| GeneOntologyBiologicalProcess | male meiotic nuclear division | 1.24e-03 | 60 | 18 | 2 | GO:0007140 | |
| GeneOntologyBiologicalProcess | regeneration | 1.28e-03 | 252 | 18 | 3 | GO:0031099 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.29e-03 | 569 | 18 | 4 | GO:0034329 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in inflammatory response | 1.36e-03 | 63 | 18 | 2 | GO:0002269 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | 1.46e-03 | 589 | 18 | 4 | GO:0031349 | |
| GeneOntologyBiologicalProcess | p38MAPK cascade | 1.54e-03 | 67 | 18 | 2 | GO:0038066 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 1.55e-03 | 598 | 18 | 4 | GO:0080135 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor signaling pathway | 1.63e-03 | 69 | 18 | 2 | GO:0048010 | |
| GeneOntologyBiologicalProcess | glial cell activation | 1.68e-03 | 70 | 18 | 2 | GO:0061900 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.96e-03 | 292 | 18 | 3 | GO:0043488 | |
| GeneOntologyBiologicalProcess | innate immune response | 1.98e-03 | 1092 | 18 | 5 | GO:0045087 | |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 2.00e-03 | 294 | 18 | 3 | GO:0002221 | |
| GeneOntologyBiologicalProcess | axon development | 2.01e-03 | 642 | 18 | 4 | GO:0061564 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 2.02e-03 | 77 | 18 | 2 | GO:0048255 | |
| GeneOntologyBiologicalProcess | response to wounding | 2.21e-03 | 659 | 18 | 4 | GO:0009611 | |
| GeneOntologyBiologicalProcess | synapse assembly | 2.28e-03 | 308 | 18 | 3 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 2.28e-03 | 308 | 18 | 3 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 2.30e-03 | 309 | 18 | 3 | GO:0061013 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 2.36e-03 | 312 | 18 | 3 | GO:0002758 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.38e-03 | 313 | 18 | 3 | GO:0098742 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.58e-03 | 87 | 18 | 2 | GO:1902373 | |
| GeneOntologyBiologicalProcess | toll-like receptor signaling pathway | 2.63e-03 | 88 | 18 | 2 | GO:0002224 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 2.63e-03 | 88 | 18 | 2 | GO:0043489 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 2.70e-03 | 696 | 18 | 4 | GO:0034655 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 2.75e-03 | 90 | 18 | 2 | GO:0060042 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 2.81e-03 | 91 | 18 | 2 | GO:0006446 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 2.84e-03 | 333 | 18 | 3 | GO:0002218 | |
| GeneOntologyBiologicalProcess | dendrite development | 2.89e-03 | 335 | 18 | 3 | GO:0016358 | |
| GeneOntologyBiologicalProcess | central nervous system development | 2.96e-03 | 1197 | 18 | 5 | GO:0007417 | |
| GeneOntologyBiologicalProcess | sensory organ development | 3.20e-03 | 730 | 18 | 4 | GO:0007423 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 3.45e-03 | 101 | 18 | 2 | GO:1902369 | |
| GeneOntologyBiologicalProcess | neuroinflammatory response | 3.45e-03 | 101 | 18 | 2 | GO:0150076 | |
| GeneOntologyBiologicalProcess | neural retina development | 3.52e-03 | 102 | 18 | 2 | GO:0003407 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 3.72e-03 | 105 | 18 | 2 | GO:0048708 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron apoptotic process | 4.08e-03 | 110 | 18 | 2 | GO:0043525 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 4.37e-03 | 114 | 18 | 2 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 4.45e-03 | 115 | 18 | 2 | GO:1903312 | |
| GeneOntologyBiologicalProcess | spinal cord development | 4.75e-03 | 119 | 18 | 2 | GO:0021510 | |
| Domain | I-set | 1.72e-08 | 190 | 18 | 6 | PF07679 | |
| Domain | Ig_I-set | 1.72e-08 | 190 | 18 | 6 | IPR013098 | |
| Domain | Ig_sub2 | 6.09e-08 | 235 | 18 | 6 | IPR003598 | |
| Domain | IGc2 | 6.09e-08 | 235 | 18 | 6 | SM00408 | |
| Domain | fn3 | 3.61e-07 | 162 | 18 | 5 | PF00041 | |
| Domain | FN3 | 6.97e-07 | 185 | 18 | 5 | SM00060 | |
| Domain | FN3 | 1.00e-06 | 199 | 18 | 5 | PS50853 | |
| Domain | FN3_dom | 1.27e-06 | 209 | 18 | 5 | IPR003961 | |
| Domain | Ig_sub | 1.87e-06 | 421 | 18 | 6 | IPR003599 | |
| Domain | IG | 1.87e-06 | 421 | 18 | 6 | SM00409 | |
| Domain | MAPKAPK_C | 2.63e-06 | 3 | 18 | 2 | IPR027442 | |
| Domain | - | 2.63e-06 | 3 | 18 | 2 | 4.10.1170.10 | |
| Domain | IG_LIKE | 4.54e-06 | 491 | 18 | 6 | PS50835 | |
| Domain | Ig-like_dom | 5.22e-06 | 503 | 18 | 6 | IPR007110 | |
| Domain | - | 2.52e-05 | 663 | 18 | 6 | 2.60.40.10 | |
| Domain | Immunoglobulin | 2.84e-05 | 190 | 18 | 4 | IPR013151 | |
| Domain | ig | 2.84e-05 | 190 | 18 | 4 | PF00047 | |
| Domain | Ig-like_fold | 3.59e-05 | 706 | 18 | 6 | IPR013783 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.98e-03 | 69 | 18 | 2 | IPR020636 | |
| Domain | Ig_2 | 2.21e-03 | 73 | 18 | 2 | PF13895 | |
| Domain | ZINC_PROTEASE | 3.95e-03 | 98 | 18 | 2 | PS00142 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.64e-05 | 7 | 13 | 2 | MM14672 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 5.15e-05 | 12 | 13 | 2 | MM14657 | |
| Pathway | REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE | 5.79e-05 | 85 | 13 | 3 | MM14645 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 6.09e-05 | 13 | 13 | 2 | M1441 | |
| Pathway | BIOCARTA_HSP27_PATHWAY | 7.10e-05 | 14 | 13 | 2 | M2587 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 9.13e-05 | 99 | 13 | 3 | MM14660 | |
| Pathway | REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE | 1.22e-04 | 109 | 13 | 3 | M29565 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 1.22e-04 | 109 | 13 | 3 | M27012 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.36e-04 | 995 | 13 | 6 | MM14661 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE | 1.43e-04 | 115 | 13 | 3 | M27013 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.48e-04 | 20 | 13 | 2 | M12256 | |
| Pathway | PID_P38_MK2_PATHWAY | 1.63e-04 | 21 | 13 | 2 | M199 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 1.70e-04 | 122 | 13 | 3 | MM14640 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 1.96e-04 | 23 | 13 | 2 | M17243 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 2.14e-04 | 24 | 13 | 2 | MM15133 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.24e-04 | 134 | 13 | 3 | M3574 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 2.52e-04 | 26 | 13 | 2 | MM14716 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 2.72e-04 | 1128 | 13 | 6 | M1036 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 3.44e-04 | 155 | 13 | 3 | MM14665 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 4.33e-04 | 34 | 13 | 2 | M13881 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 4.51e-04 | 170 | 13 | 3 | M7494 | |
| Pathway | WP_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION | 4.86e-04 | 36 | 13 | 2 | MM15967 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 5.13e-04 | 37 | 13 | 2 | MM14899 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 5.13e-04 | 37 | 13 | 2 | M42558 | |
| Pathway | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | 5.42e-04 | 38 | 13 | 2 | M229 | |
| Pathway | WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS | 7.27e-04 | 44 | 13 | 2 | M39673 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 8.65e-04 | 48 | 13 | 2 | MM15069 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.09e-03 | 532 | 13 | 4 | M27870 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.30e-03 | 59 | 13 | 2 | MM15128 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 1.49e-03 | 63 | 13 | 2 | MM14714 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.88e-03 | 71 | 13 | 2 | M27382 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 1.93e-03 | 281 | 13 | 3 | MM15130 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.99e-03 | 73 | 13 | 2 | MM15126 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.10e-03 | 75 | 13 | 2 | MM14652 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 2.15e-03 | 76 | 13 | 2 | M1749 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.44e-03 | 81 | 13 | 2 | M13863 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 3.00e-03 | 90 | 13 | 2 | M820 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.41e-03 | 96 | 13 | 2 | MM14592 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.91e-03 | 103 | 13 | 2 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 4.14e-03 | 106 | 13 | 2 | M27077 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 5.02e-03 | 117 | 13 | 2 | M19248 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.19e-03 | 119 | 13 | 2 | MM14901 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 5.71e-03 | 125 | 13 | 2 | M27186 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.93e-03 | 418 | 13 | 3 | MM15587 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 6.44e-03 | 133 | 13 | 2 | M16476 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 8.30e-03 | 472 | 13 | 3 | MM14539 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 8.35e-03 | 473 | 13 | 3 | M874 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 8.60e-03 | 478 | 13 | 3 | M27620 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 8.65e-03 | 155 | 13 | 2 | M522 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 1.03e-02 | 511 | 13 | 3 | MM15330 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.37e-02 | 197 | 13 | 2 | M27188 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.42e-02 | 575 | 13 | 3 | M29853 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 2.53e-07 | 2 | 18 | 2 | 15703275 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 30150416 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 24935968 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 29187369 | ||
| Pubmed | Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis. | 2.53e-07 | 2 | 18 | 2 | 23372691 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 27694493 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 2.53e-07 | 2 | 18 | 2 | 12230981 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 31167133 | ||
| Pubmed | Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. | 2.53e-07 | 2 | 18 | 2 | 24082115 | |
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 2.53e-07 | 2 | 18 | 2 | 15213259 | |
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 2.53e-07 | 2 | 18 | 2 | 27644106 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 10781029 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 23608535 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 26068544 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 8774846 | ||
| Pubmed | p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. | 7.59e-07 | 3 | 18 | 2 | 20724476 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 7799959 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 21586572 | ||
| Pubmed | Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. | 7.59e-07 | 3 | 18 | 2 | 8846784 | |
| Pubmed | The MK2/3 cascade regulates AMPAR trafficking and cognitive flexibility. | 7.59e-07 | 3 | 18 | 2 | 25134715 | |
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 33427298 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 11335727 | ||
| Pubmed | Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. | 1.52e-06 | 4 | 18 | 2 | 28011639 | |
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 21575178 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 31334837 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 20484669 | ||
| Pubmed | The cell adhesion molecule Sdk1 shapes assembly of a retinal circuit that detects localized edges. | 2.53e-06 | 5 | 18 | 2 | 34545809 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 14578350 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 28920954 | ||
| Pubmed | The Role of TTP Phosphorylation in the Regulation of Inflammatory Cytokine Production by MK2/3. | 2.53e-06 | 5 | 18 | 2 | 31527197 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 17906627 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 30687002 | ||
| Pubmed | Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. | 3.79e-06 | 6 | 18 | 2 | 29440485 | |
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 17030606 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 25693418 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 32424229 | ||
| Pubmed | MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells. | 7.07e-06 | 8 | 18 | 2 | 19369945 | |
| Pubmed | 1.14e-05 | 10 | 18 | 2 | 29229781 | ||
| Pubmed | 1.39e-05 | 11 | 18 | 2 | 15850461 | ||
| Pubmed | 1.66e-05 | 12 | 18 | 2 | 12171600 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 1.66e-05 | 12 | 18 | 2 | 9297626 | |
| Pubmed | 3.88e-05 | 382 | 18 | 4 | 37249651 | ||
| Pubmed | Sidekick 2 directs formation of a retinal circuit that detects differential motion. | 6.36e-05 | 23 | 18 | 2 | 26287463 | |
| Pubmed | Nerve growth factor signaling, neuroprotection, and neural repair. | 8.16e-05 | 26 | 18 | 2 | 11520933 | |
| Pubmed | 1.67e-04 | 37 | 18 | 2 | 16707424 | ||
| Pubmed | 1.75e-04 | 214 | 18 | 3 | 22199357 | ||
| Pubmed | 3.00e-04 | 257 | 18 | 3 | 16335952 | ||
| Pubmed | 3.30e-04 | 52 | 18 | 2 | 26633812 | ||
| Interaction | RYK interactions | 3.24e-05 | 212 | 18 | 4 | int:RYK | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 5.69e-03 | 290 | 18 | 2 | chr1q32 | |
| GeneFamily | Fibronectin type III domain containing | 9.57e-08 | 160 | 14 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.87e-08 | 161 | 14 | 5 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.16e-05 | 193 | 14 | 4 | 594 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 3.05e-05 | 11 | 14 | 2 | 1156 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN | 8.90e-06 | 198 | 18 | 4 | M4959 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.58e-07 | 193 | 18 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.46e-05 | 160 | 18 | 3 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 173 | 18 | 3 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 173 | 18 | 3 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-05 | 179 | 18 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 5.00e-05 | 181 | 18 | 3 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 5.25e-05 | 184 | 18 | 3 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.25e-05 | 184 | 18 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.33e-05 | 185 | 18 | 3 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.42e-05 | 186 | 18 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.42e-05 | 186 | 18 | 3 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.42e-05 | 186 | 18 | 3 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | IIH-pDC-|IIH / Condition, Cell_class and T cell subcluster | 5.51e-05 | 187 | 18 | 3 | ad87b146ea8dd9f695e722f8f0e8e1057c7f3167 | |
| ToppCell | IIH-pDC|IIH / Condition, Cell_class and T cell subcluster | 5.51e-05 | 187 | 18 | 3 | 5e59e9153a18bcfb5c8dc94599080216661de7ce | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.51e-05 | 187 | 18 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-05 | 189 | 18 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 5.77e-05 | 190 | 18 | 3 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 5.77e-05 | 190 | 18 | 3 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | Control-Myeloid-pDC|Control / Disease, Lineage and Cell Type | 5.86e-05 | 191 | 18 | 3 | 473f904fe244d919ce561139591a2be12cc9fa6b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-05 | 191 | 18 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | BLOOD--(3)_DC_(cDC+pDC)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.96e-05 | 192 | 18 | 3 | e290c55a1321e9e577f49e8ba20501b2c8150044 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.96e-05 | 192 | 18 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.05e-05 | 193 | 18 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 6.05e-05 | 193 | 18 | 3 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 6.05e-05 | 193 | 18 | 3 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.05e-05 | 193 | 18 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 194 | 18 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.24e-05 | 195 | 18 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.24e-05 | 195 | 18 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.24e-05 | 195 | 18 | 3 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.33e-05 | 196 | 18 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.43e-05 | 197 | 18 | 3 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.52e-05 | 198 | 18 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 6.52e-05 | 198 | 18 | 3 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.52e-05 | 198 | 18 | 3 | c26c909e95225440abdf558b1b858ffc06177000 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 6.52e-05 | 198 | 18 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 6.62e-05 | 199 | 18 | 3 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.62e-05 | 199 | 18 | 3 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 6.62e-05 | 199 | 18 | 3 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.62e-05 | 199 | 18 | 3 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.62e-05 | 199 | 18 | 3 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 6.62e-05 | 199 | 18 | 3 | 2f6074a2fd3323f258be03042f77929640ad0a75 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.72e-05 | 200 | 18 | 3 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-05 | 200 | 18 | 3 | 9e8659bbc6547f1ab7f4e0a81b0bcbe158e9e2f7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.72e-05 | 200 | 18 | 3 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-05 | 200 | 18 | 3 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.06e-04 | 91 | 18 | 2 | 78e2e65beb15bf1e251974c72fbcfab817492772 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.06e-04 | 91 | 18 | 2 | f59908093416ca7b3ca27019d71c79acbdea18cb | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.06e-04 | 91 | 18 | 2 | 104d2ab9fe5cc404388c32fafb34e421c2e138be | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.74e-04 | 96 | 18 | 2 | d98df92856840602a82d3f050bf0a1543445cac0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.74e-04 | 96 | 18 | 2 | bf62c29da66aa3eefdc59337dfb3cd0467f04f10 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.36e-04 | 107 | 18 | 2 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.36e-04 | 107 | 18 | 2 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-04 | 114 | 18 | 2 | c3feca81edee445cbe5e46a07e1a59327dc2e981 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-04 | 114 | 18 | 2 | 89350483d2ce57afc612fe25398e35af121d50f0 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.48e-04 | 114 | 18 | 2 | fceb7cc590a47380145fc0d854c9f2350dbb0a59 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.48e-04 | 114 | 18 | 2 | 2cc5d2da5573650c5232a01e2d2128082c4bffcb | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-03 | 136 | 18 | 2 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-03 | 136 | 18 | 2 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | CTRL-Lymphoid-pDC|CTRL / Disease state, Lineage and Cell class | 1.40e-03 | 139 | 18 | 2 | bbc10812b0c5b8c85e78171c12316becde8895c3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-03 | 140 | 18 | 2 | e16e31d6310347f1fe72051dd0d7650d090e6d3c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-03 | 141 | 18 | 2 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 147 | 18 | 2 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 147 | 18 | 2 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | ASK454-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.61e-03 | 149 | 18 | 2 | 078792d5272f1881757dc47daa96e87449cf5d34 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.63e-03 | 150 | 18 | 2 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 1.65e-03 | 151 | 18 | 2 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 1.65e-03 | 151 | 18 | 2 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-03 | 152 | 18 | 2 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-03 | 153 | 18 | 2 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-03 | 157 | 18 | 2 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-03 | 158 | 18 | 2 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-03 | 158 | 18 | 2 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-03 | 158 | 18 | 2 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-03 | 158 | 18 | 2 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.83e-03 | 159 | 18 | 2 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.83e-03 | 159 | 18 | 2 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.83e-03 | 159 | 18 | 2 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.85e-03 | 160 | 18 | 2 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.85e-03 | 160 | 18 | 2 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-03 | 160 | 18 | 2 | 6215ac6123a295f3c2f033786602a57b2e2e1177 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-03 | 160 | 18 | 2 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.85e-03 | 160 | 18 | 2 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-03 | 160 | 18 | 2 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-03 | 161 | 18 | 2 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 1.88e-03 | 161 | 18 | 2 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-03 | 161 | 18 | 2 | 4362fe0c151f49eae7372b9673bac64d980a8389 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-03 | 161 | 18 | 2 | 5cd483b73bcb3615ea56eb81c1c293e61b84b66d | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 161 | 18 | 2 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-03 | 162 | 18 | 2 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-03 | 162 | 18 | 2 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.92e-03 | 163 | 18 | 2 | 4be3158f2a0ab460cfea8080a7370922910b5da9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-03 | 164 | 18 | 2 | 7077683afee91828ad2b95e0f81c2b27aae0f831 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-03 | 164 | 18 | 2 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-03 | 164 | 18 | 2 | 10741c7706a37b24aa08a300b27d60d6b8600167 | |
| Disease | anxiety disorder, stress-related disorder | 2.31e-05 | 12 | 18 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | atherosclerosis (is_marker_for) | 2.31e-04 | 37 | 18 | 2 | DOID:1936 (is_marker_for) | |
| Disease | Drug-induced agranulocytosis, response to clozapine | 2.98e-04 | 42 | 18 | 2 | GO_0097338, HP_0012235 | |
| Disease | Hepatic fibrosis | 4.06e-04 | 49 | 18 | 2 | HP_0001395 | |
| Disease | conotruncal heart malformations | 2.17e-03 | 114 | 18 | 2 | MONDO_0016581 | |
| Disease | Tinnitus | 2.81e-03 | 130 | 18 | 2 | HP_0000360 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.90e-03 | 132 | 18 | 2 | DOID:10652 (is_implicated_in) | |
| Disease | glycine measurement | 3.12e-03 | 137 | 18 | 2 | EFO_0009767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HELPPQSQPWVMPSQ | 726 | Q9UKF5 | |
| EQGPHQVPWMEKAPA | 336 | P28799 | |
| FKQWMENPNNNPIHP | 776 | P15144 | |
| PQPPQNPSMVQWSHC | 716 | Q9Y2K5 | |
| VPAQPSPQIHWMKDG | 261 | Q15109 | |
| NHPWIMQSTKVPQTP | 321 | P49137 | |
| HPWINQSMVVPQTPL | 301 | Q16644 | |
| VPMLQVWTADKPHPQ | 211 | Q09161 | |
| MEPEHPVGNWQKHNV | 466 | Q13332 | |
| NGNPKPTVQWMVNGE | 361 | O94856 | |
| PHQNQWTVCRPMKEP | 501 | Q9NXS3 | |
| PPQQPQQQDSVWGMN | 1221 | Q6Y7W6 | |
| QNPWQPKPHVLDMQG | 116 | Q96LM5 | |
| KISEMTQWTPPPQNH | 481 | Q9NY37 | |
| MVQWQPPPETEHNGV | 786 | Q7Z5N4 | |
| SIMIQWQPPPESHQN | 706 | Q58EX2 | |
| PTWMNVQTKNNTPIP | 476 | A2RUB1 | |
| MIHWQPPAPATQNGQ | 651 | Q92859 | |
| GHQVSTPPNEQKPVW | 131 | Q9Y5A6 | |
| VWQPTKGQMPHQPEQ | 661 | Q3C1V9 |